Get the Stockscreener App
23.21
1.69%
-0.40
Progyny Inc stock is traded at $23.21, with a volume of 739.93K.
It is down -1.69% in the last 24 hours and up +7.01% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$23.61
Open:
$23.46
24h Volume:
739.93K
Relative Volume:
0.66
Market Cap:
$1.92B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
36.84
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
+8.15%
1M Performance:
+7.01%
6M Performance:
+23.72%
1Y Performance:
-17.64%
1-Day Range:
$23.05
$23.60
1-Week Range:
$21.20
$24.66
52-Week Range:
$13.39
$30.42
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
23.21 | 1.92B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
304.10 | 275.58B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
340.67 | 86.74B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
303.27 | 82.87B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
64.78 | 81.29B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
230.67 | 28.00B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Progyny and Oura: A Wearable Tech Revolution in Women's Health and Its Implications for Investors - AInvest
Progyny partners with Oura for women’s health monitoring By Investing.com - Investing.com South Africa
Progyny, Inc. Partners with ŌURA to Enhance Women's Health Insights Through Wearable Technology - Quiver Quantitative
Progyny Partners with ŌURA to Empower Women and Their Care - GlobeNewswire
Progyny Partners Oura Ring: Game-Changing Data Integration Reshapes Fertility Care - Stock Titan
Progyny rises on guidance update - MSN
Progyny upgraded to Outperform at Leerink after positive pre-announcement - MSN
Progyny Inc Stock (PGNY): Strong Growth Post Q1 Results - Value The Markets
Strength Seen in Progyny (PGNY): Can Its 13.2% Jump Turn into More Strength? - Nasdaq
Progyny (PGNY) Receives Rating Upgrade from Leerink Partners | P - GuruFocus
Progyny stock gains as BTIG reiterates Buy rating on favorable Q2 outlook - Investing.com Nigeria
Under the Radar: Hunting Smart in the Alleyway of Value and Growth - Benzinga
Progyny stock (PGNY) rises: what’s going on with Progyny Inc? - Markets.com
Progyny Expects Q2 Results 'Slightly Above' Guidance, Enters $200 Million Revolver; Shares Rise - MarketScreener
Progyny stock rises on guidance update (PGNY:NASDAQ) - Seeking Alpha
Progyny Reveals $200 Mln Revolving Credit Facility, Sees Q2 Results Slightly Ahead Of Expectations - Nasdaq
Progyny, Inc. Enters into A Revolving Credit Facility - MarketScreener
Progyny Secures $200M Credit Facility with JPMorgan - TipRanks
Progyny secures $200 million revolving credit facility, expects Q2 results above guidance - Investing.com
Progyny, Inc. Secures $200 Million Credit Facility to Enhance Financial Flexibility and Anticipates Positive Second Quarter Results - Nasdaq
Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report | PGNY Stock News - GuruFocus
Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report - The Manila Times
Progyny Boosts Financial Muscle with $200M Credit Line as Q2 Results Set to Beat Expectations - Stock Titan
(PGNY) Proactive Strategies - news.stocktradersdaily.com
Progyny’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Here’s Why Progyny (PGNY) Rebounded in Q1 - Insider Monkey
Progyny (PGNY) Expands Women's Health Benefits with New Partners - GuruFocus
Progyny Expands Women's Health Offerings with New Pelvic Floor Therapy Services - Nasdaq
One-Third of Women Need It: Progyny Unveils Game-Changing Pelvic Health Solution with Digital Therapy - Stock Titan
(PGNY) Investment Analysis - news.stocktradersdaily.com
Progyny (PGNY) Soared on Expanding Client Base and Improving Utilization Trends - Insider Monkey
Progyny director Scott Cheryl sells $59,037 in stock By Investing.com - Investing.com Canada
Progyny director Scott Cheryl sells $59,037 in stock - Investing.com Australia
Insider Sell: Cheryl Scott Sells Shares of Progyny Inc (PGNY) - GuruFocus
Progyny Stock Trades Higher On Collaboration With Amazon’s Health Benefits Connector: Retail’s Yet To Be Impressed - Asianet Newsable
Progyny (PGNY) and Amazon Team Up to Enhance Women's Health Serv - GuruFocus
Progyny Joins Amazon's Health Benefits Connector Program as Firs - GuruFocus
Progyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building Solution | PGNY Stock News - GuruFocus
Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution - GlobeNewswire
Progyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building Solution - The Manila Times
Breakthrough Partnership: Amazon Picks Progyny as Exclusive Women's Health Provider for 6.7M Lives - Stock Titan
(PGNY) On The My Stocks Page - news.stocktradersdaily.com
Progyny, Inc. (NASDAQ:PGNY) Stake Reduced by California State Teachers Retirement System - Defense World
Progyny, Inc. (PGNY) Stock Analysis: Uncovering a 20.97% Upside Potential in Healthcare Plans - DirectorsTalk Interviews
Progyny, Inc. (NASDAQ:PGNY) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Progyny, Inc. (NASDAQ:PGNY) Shares Purchased by Nuveen Asset Management LLC - Defense World
Progyny appoints Elizabeth Bierbower to board By Investing.com - Investing.com South Africa
Progyny (PGNY) Welcomes Elizabeth Bierbower to Its Board of Dire - GuruFocus
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbo - GuruFocus
Progyny appoints Elizabeth Bierbower to board - Investing.com Australia
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors | PGNY Stock News - GuruFocus
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):